Effect of experimental spinal cord injury on salicylate bioavailability after oral aspirin administration

Journal of Pharmacological and Toxicological Methods

Volumn 42, Issue 2, 1999, Pages 93-97

  Fuentes Lara, Griselda ^a,c   Guízar Sahagún, Gabriel ^a,b   García López, Patricia ^c,d  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Ctro Medico Nac Siglo XXI I   (Mexico)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

^d INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

Aspirin; Bioavailability; Salicylates; Salicylic acid; Spinal cord injury

Indexed keywords

ACETYLSALICYLIC ACID; SALICYLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CONTUSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FEMALE; GASTROINTESTINAL ABSORPTION; NONHUMAN; RAT; SPINAL CORD INJURY;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BIOLOGICAL AVAILABILITY; FEMALE; RATS; RATS, SPRAGUE-DAWLEY; SALICYLATES; SPINAL CORD INJURIES;

ANIMALIA;

EID: 0343962638     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8719(00)00048-4     Document Type: Article

References (28)

1. Allen A.R. Surgery of experimental lesions of spinal cord equivalent to crush injury of fracture dislocation of spinal column. a preliminary report J Am Med Assoc. 57:1911;878-880.
2. Bagnall W.E., Kelleher J., Walker B.E., Losowsky M.S. The gastrointestinal absorption of paracetamol in the rat. J Pharm Pharmacol. 31:1979;157-160.
3. Balant L.P., Benet L.Z., Blume H., Bozler G., Breimer D.D., Eichelbaum M., Gundert-Remy U., Hirtz J.L., Mutschler E., Midha K.K., Rauws A.G., Ritschel W.A., Sansom L.N., Skelly J.P., Vollmer K.O. Is there a need for more precise definitions of bioavailability? Eur J Clin Pharmacol. 40:1991;123-126.
4. Castañeda-Hernández G., Castillo-Méndez M.S., López-Muñoz F.J., Granados-Soto V., Flores-Murrieta F.J. Potentiation by caffeine of the analgesic effect of aspirin in the pain-induced functional impairment model in the rat. Can J Physiol Pharmacol. 72:1994;1127-1131.
5. Cruz L., Castañeda-Hernández G., Navarrete A. Ingestion of chilli peper (Capsicum annuun) reduces salicylate bioavailability after oral aspirin administration in the rat. Can J Physiol Pharmacol. 77:1999;441-446.
6. Das G.D. Perspectives in anatomy and pathology of paraplegia in experimental animals. Brain Res Bull. 22:1989;7-32.
7. Fealey R.D., Szurszewski J.H., Merrit J.L., DiMagno E.P. Effect of traumatic spinal cord transection on human upper gastrointestinal motility and gastric emptying. Gastroenterology. 87:1984;69-75.
8. García-López P., Pérez-Urizar J., Ibarra A., Guízar-Sahagún G., Flores-Murrieta F.J., Grijalva I., Castañeda-Hernández G. Pharm Sci. 1:1995;133-135.
9. García-López P., Pérez-Urizar J., Ibarra A., Grijalva I., Madrazo I., Flores-Murrieta F.J., Castañeda-Hernández G., Guízar-Sahagún G. Comparison between Sprague-Dawley and Wistar rats as an experimental model of pharmacokinetic alterations induced by spinal cord injury. Arch Med Res. 27:1996;453-457.
10. García-López P., Pérez-Urizar J., Madrazo I., Guízar-Sahagún G., Castañeda-Hernández G. Oral paracetamol bioavailability in rats subjected to experimental spinal cord injury. Biopharm Drug Dispos. 18:1997;203-211.
11. Gibaldi, M. (1991). Biopharmaceutics and Clinical Pharmacokinetcs, 4th ed. (pp. 40-60). Philadelphia and London: Lea & Febiger.
12. Gilman T.M., Brunnemann S.R., Segal J.L. Comparison of population pharmacokinetic models for gentamicin in spinal cord injury and able-bodied patients. Antimicrob Agents Chemother. 37:1993;93-99.
13. Guízar-Sahagún G., Grijalva I., Madrazo I., Franco-Bourland R., Salgado-Ceballos H., Ibarra A., Larriva-Sahd J. Neuroprotection of completely lacerated spinal cord of adult rats by homotropic and heterotropic transplantation. Restor Neurol Neurosci. 61:1994;61-70.
14. Guízar-Sahagún G., García-López P., Espitia A.L., Méndez S., Castañeda-Henández G., Madrazo I., Franco-Bourland R. Histochemical evidence for the increased expression of nicotinamide adenine dinucleotide phosphate-dependent diaphorase in neurons of the myenteric plexus after acute spinal cord injury in adult rats. Neurosci Lett. 206:1996;185-188.
15. Guízar-Sahagún G., Castañeda-Hernández G., García-López P., Franco-Bourland R., Grijalva I., Madrazo I. Pathophysiological mechanisms involved in systemic and metabolic alterations secondary to spinal cord injury. Proc West Pharmacol Soc. 41:1998;237-240.
16. Halstead L.S., Feldman S., Claus-Walker J., Patel V.C. Drug absorption in spinal cord injury. Arch Phys Med Rehab. 66:1985;298-301.
17. Hall E.D., Wolf D.L. A pharmacological analysis of the pathophysiological mechanisms of posttraumatic spinal cord ischemia. J Neurosurg. 64:1986;951-961.
18. Heading R.C., Nimmo J., Prescott L.F., Tothill P. The dependence of paracetamol absorption on the rate of gastric emptying. Br J Pharmacol. 47:1973;415-421.
19. Higgs G.A., Salmon J.A., Henderson B., Vane J.R. Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity. Proc Natl Acad Sci USA. 84:1987;1417-1420.
20. Holtz A., Nystrom B. Neuropathological changes and neurological function after spinal cord compression in the rat. J Neurotrauma. 7:1990;155-167.
21. Krassioukov A.V., Weaver L.C. Episodic hypertension due to autonomic dysreflexia in acute and chronic spinal cord-injured rats. Am J Physiol. 268:1995;H2077-H2083.
22. Pabst G., Jaeger H. Review of methods and criteria for the evaluation of bioequivalence studies. Eur J Clin Pharmacol. 38:1990;5-10.
23. Segal J.L., Brunnemann S.R. Clinical pharmacokinetics in patients with spinal cord injury. Clin Pharmacokinet. 17:1989;109-129.
24. Segal J.L., Brunnemann S.R., Gordon S.K., Eltorai I.M. Decreased theophylline bioavailability and impaired gastric emptying in spinal cord injury. Curr Ther Res. 38:1985;831-846.
25. Segal J.L., Brunnemann S.R., Gordon S.K., Eltorai I.M. Amikacin pharmacokinetics in patients with spinal cord injury. Pharmacotherapy. 8:1988;79-81.
26. Segal J.L., Brunnemann S.R., Eltorai I.M., Vulpe M. Decreased systemic clearance of lorazepam in humans with spinal cord injury. J Clin Pharmacol. 31:1991;651-656.
27. Stover S.L., Fine P.R. The epidemiology and economics of spinal cord injury. Paraplegia. 25:1987;225-228.
28. Wentjes M.G., Levy G. Non-linear pharmacokinetics of aspirin in the rat. J Pharmacol Exp Ther. 245:1988;809-815.